Could a simple supplement boost muscle strength before lung transplant?
NCT ID NCT07660991
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether adding a dietary supplement called hydroxymethylbutyrate (HMB) to standard pulmonary rehabilitation helps lung transplant candidates improve muscle mass, strength, and overall health. Participants are adults aged 40-50 who are on the waiting list for a lung transplant. Half will receive HMB for 8 weeks alongside rehab and diet therapy, while the other half receive only rehab and diet therapy. The goal is to see if HMB can better prepare patients for surgery and recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hydroxymethylbutyrate (HMB)
- What this could lead to
- If it works, this could help lung transplant candidates maintain muscle mass and function before surgery, potentially improving recovery and quality of life.
- What could go wrong
- This is a small, early-stage study with only 30 participants, so results may not apply to everyone. HMB is generally safe but may not provide significant benefits over rehabilitation alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUN TRANSPLANT CANDIDATES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Koşuyolu Yüksek Ihtisas Eğitim Ve Araştırma Hastanesi
Istanbul, Kartal, 34865, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can muscle strength predict lung transplant recovery?
- Blood markers may flag lung transplant danger — study investigates
- Your genes may hold the key to safer lung transplants
- Blood test clues could make antifungal dosing safer for transplant patients
- AI model could predict who needs a lung transplant for rare emphysema
- New pain block could cut opioid use after lung transplants